Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle and SK Capital Partners at a discount, ending ...
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic ...
8hon MSN
A Connecticut boy is among four children all born with severe childhood blindness who gained “life-changing improvements” to ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback